Extracellular matrix composition beads for cell culture
US-2016304832-A1 · Oct 20, 2016 · US
US11560545B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11560545-B2 |
| Application number | US-201816610325-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 1, 2018 |
| Priority date | May 2, 2017 |
| Publication date | Jan 24, 2023 |
| Grant date | Jan 24, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are methods of controlling disassociation of cells from a carrier, compositions, and methods of collecting cells. The methods of controlling disassociation of cells from a carrier may include contacting a polymeric carrier with one or more digesting agents to disassociate at least a portion of a plurality of cells from the polymeric carrier. The polymeric carrier may be crosslinked with a crosslinker including at least one of a redox sensitive moiety, a UV light sensitive moiety, a pH sensitive moiety, and a temperature sensitive moiety.
Opening claim text (preview).
The invention claimed is: 1. A method of controlling disassociation of cells from a carrier, the method comprising: providing a polymeric carrier and a plurality of cells adhered to the polymeric carrier, wherein the polymeric carrier is a microcarrier; and contacting the polymeric carrier with one or more digesting agents to disassociate at least a portion of the plurality of cells from the polymeric carrier; wherein the polymeric carrier comprises gelatin, and is crosslinked with a crosslinker comprising at least one redox sensitive moiety, wherein the at least one redox sensitive moiety comprises a disulfide bond, and the crosslinker comprises a compound having the following structure— wherein R 1 and R 2 are independently selected from a divalent C 1 -C 20 hydrocarbyl. 2. The method of claim 1 , wherein R 1 and R 2 are unsubstituted divalent C 1 -C 5 hydrocarbyls, and the crosslinker has the following structure: 3. The method of claim 1 , wherein R 1 and R 2 are unsubstituted divalent C 2 hydrocarbyls, and the crosslinker comprises 1,2-bis-(2-isocyanatoethyl)disulfide (DIDS): 4. The method of claim 1 , wherein the plurality of cells comprises human Mesenchymal stem cells (hMSCs), endothelial cells, or a combination thereof. 5. The method of claim 1 , wherein the polymeric carrier further comprises dextran, hyaluronic acid, agarose, chitosan, alginate, polyvinyl alcohol, polyamino acid, calcium alginate, polyacrylate, polyethylene glycol, polyethylene imine, polyanhydride, or a combination thereof. 6. The method of claim 1 , wherein the polymeric carrier further comprises dextran, hyaluronic acid, agarose, chitosan, alginate, polyvinyl alcohol, polyamino acid, or a combination thereof. 7. The method of claim 1 , wherein the polymeric carrier is a polymeric carrier bead. 8. The method of claim 1 , wherein the one or more digesting agents comprises a reducing agent. 9. The method of claim 8 , wherein the reducing agent comprises dithiothreitol (DTT), cysteine, glutathione, or a combination thereof. 10. The method of claim 8 , wherein the reducing agent comprises a solution of dithiothreitol (DTT) having a concentration of about 5 mM to about 25 mM. 11. The method of claim 10 , wherein the solution of dithiothreitol further comprises sodium citrate, trypsin, or a combination thereof. 12. The method of claim 1 , wherein the one or more digesting agents comprises an enzyme. 13. The method of claim 12 , wherein the enzyme comprises collagenase, dispase-like protease, trypsin, urease, papain, bromelain, pancreatin, gelatinase (MMP2 and MMP9), or a combination thereof. 14. The method of claim 1 , wherein the one or more digesting agents comprises a reducing agent and an enzyme. 15. The method of claim 1 , wherein the ratio of the crosslinker (mmol) to the polymeric carrier (g) is about 0.1 mmol:10 g to about 1.9 mmol:10 g.
Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof · CPC title
Alginic acid; Derivatives thereof · CPC title
Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers · CPC title
Cross-linking · CPC title
Crosslinking · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.